The AstraZeneca US phase 3 trial took about 7 months.
https://clinicaltrials.gov/ct2/show/NCT04516746
In this case, US regulators took issue with the company's press release, rather than the results of the trial itself.
https://clinicaltrials.gov/ct2/show/NCT04516746
In this case, US regulators took issue with the company's press release, rather than the results of the trial itself.
No comments yet.